Pontifax fund and Israeli institutional investors will profit from the US personalized cancer drug company's huge sale. Part of the technology was developed at the Weizmann Institute.
Continue Reading Globes English – Israeli investors profit from $11.9b Kite acquisition
"The level of responsibility for young people in the Israeli army trains them for entrepreneurship and they see startups as a way to follow the Jewish idea of Tikun Olam…
Continue Reading After Imperva And Mobileye, Here’s What’s Next For Israeli Startups